Clinical Study
Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
Table 2
Endoscopic features before and after treatment in both groups.
| | | Seven-day regimen | 14-day regimen | | | Pretreatment
number (%) | Posttreatment
number (%) | Pretreatment
number (%) | Posttreatment
number (%) |
| | Number of patients | 26 (33.3%) | 26 (33.3%) | 52 (66.7%) | 52 (66.7%) | | Oesophagitis | 2 (7.7%) | 2 (7.7%) | 6 (11.5%) | 4 (7.7%) | | Stage A | 0 (0%) | 02 (7.7%) | 2 (3.8%) | 04 (7.7%) | | Stage B | 02 (7.7%) | 0 (0%) | 4 (7.7%) | 0 (0%) | | Gastritis | 22 (84.6%) | 15 (57.7%) | 51 (98.1%) | 29 (55.8%) | | Erythematous gastritis | 10 (38.5%) | 14 (53.8%) | 39 (75.0%) | 28 (53.8%) | | Exudative gastritis | 10 (38.5%) | 01 (3.8%) | 08 (15.4%) | 01 (1.9%) | | Erosive gastritis | 02 (7.7%) | 0 (0%) | 04 (7.7%) | 0 (0%) | | Site of gastritis | | | | | | Antral | 13 (50.0%) | 14 (53.8%) | 44 (84.0%) | 28 (53.8%) | | Corporal | 01 (3.8%) | 0 (0%) | 02 (3.8%) | 0 (0%) | | Pangastric | 08 (30.8%) | 01 (3.8%) | 05 (9.6%) | 01 (1.9%) | | Duodenitis | 9 (34.6%) | 5 (19.2%) | 14 (26.9%) | 3 (5.8%) | | Erythematous duodenitis | 0 (0%) | 02 (7.7%) | 0 (0%) | 0 (0%) | | Exudative duodenitis | 05 (19.2%) | 03 (11.5%) | 05 (9.6%) | 02 (3.8%) | | Erosive duodenitis | 04 (15.4%) | 0 (0%) | 09 (17.3%) | 01 (1.9%) | | Gastric ulcer | 3 (11.5%) | 1 (3.8%) | 1 (1.9%) | 0 (0%) | | Duodenal ulcer | 4 (15.4%) | 1 (3.8%) | 2 (3.8%) | 1 (1.9%) |
|
|
